A detailed history of Murphy & Mullick Capital Management Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 22 shares of MEDP stock, worth $7,212. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22
Holding current value
$7,212
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$308.93 - $363.58 $6,796 - $7,998
22 New
22 $7.31 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.2B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Murphy & Mullick Capital Management Corp Portfolio

Follow Murphy & Mullick Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy & Mullick Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Murphy & Mullick Capital Management Corp with notifications on news.